Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

16.82USD
26 Feb 2015
Change (% chg)

$-0.10 (-0.59%)
Prev Close
$16.92
Open
$16.82
Day's High
$16.88
Day's Low
$16.65
Volume
2,956,883
Avg. Vol
2,840,420
52-wk High
$16.96
52-wk Low
$11.11

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company operates in three segments, including Cardiovascular, Rhythm Management and MedSurg. The Company’s cardiovascular segment includes Interventional Cardiology and... (more)

Overall

Beta: 1.04
Market Cap(Mil.): $22,444.21
Shares Outstanding(Mil.): 1,326.49
Dividend: --
Yield (%): --

Financials

Search Stocks

Deals of the day- Mergers and acquisitions

Feb 24 - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:

25 Feb 2015

Boston Scientific near deal to buy Endo's device unit: sources

NEW YORK - Boston Scientific Corp is close to buying Endo International PLC's AMS medical device unit, a deal that could value the business at around $2 billion, according to people familiar with the matter.

24 Feb 2015

Boston Scientific to pay J&J $600 million to settle Guidant suit

- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.

18 Feb 2015

UPDATE 1-Boston Scientific to pay J&J $600 mln to settle Guidant suit

Feb 17 - Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.

18 Feb 2015

Fitch: Boston Scientific's Settlement Reduces Liability Risk but Also Liquidity

(The following statement was released by the rating agency) CHICAGO, February 17 (Fitch) Boston Scientific Corp.'s (NYSE: BSX) ratings are unaffected by its recent settlement with Johnson & Johnson (NYSE: JNJ) regarding litigation associated with BSX's acquisition of Guidant in 2006, according to Fitch Ratings. The settlement calls for BSX to pay $600 million to JNJ during 2015. BSX will make two $300 million dollar payments, primarily using balance sheet cash without taking on any additio

18 Feb 2015

Boston Scientific to pay J&J $600 mln to settle Guidant suit

Feb 17 - Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running breach of merger lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.

18 Feb 2015

UPDATE 1-Boston Scientific profit falls as litigation costs soar

Feb 4 - Medical device maker Boston Scientific Corp posted a 19 percent fall in fourth-quarter profit as litigation charges more than doubled.

04 Feb 2015

Boston Scientific profit falls as litigation costs soar

Feb 4 - Medical device maker Boston Scientific Corp posted a 19 percent fall in fourth-quarter profit as litigation charges more than doubled.

04 Feb 2015

J&J's $7.2 bln claim against Boston Scientific now with U.S. judge

NEW YORK, Jan 21 - For more than eight years, Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial - and ultimately ill-fated - bidding war for device maker Guidant.

22 Jan 2015

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters Jan 6, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, now click on Related Co Data, now click on Co Events.

06 Jan 2015

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $47.61 +0.21
St. Jude Medical, Inc. (STJ.N) $66.80 -0.19

Earnings vs. Estimates

Search Stocks